Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Y-90-Ibritumomab Tiuxetan, Fluadarabine and TBI Based Non-Myeloablative Allogeneic Transplant Conditioning for High-Risk B-Cell Lymphoma
Blood (2010)
  • Ajay K Gopal, University of Washington
  • Kathrine Guthrie, Fred Hutchinson Cancer Research Center
  • Joseph Rajendran, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • George Oliviera, University of Washington
  • David G Maloney, Fred Hutchinson Cancer Research Center
  • Rainer F. Storb, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
November 19, 2010
Citation Information
Ajay K Gopal, Kathrine Guthrie, Joseph Rajendran, John M. Pagel, et al.. "Y-90-Ibritumomab Tiuxetan, Fluadarabine and TBI Based Non-Myeloablative Allogeneic Transplant Conditioning for High-Risk B-Cell Lymphoma" Blood Vol. 116 Iss. 21 (2010) p. 33 - 33
Available at: http://works.bepress.com/john-pagel/191/